The bioactivity and ion release of titanium-containing glass polyalkenoate cements for medical applications

Inamori School of Engineering, Alfred University, Alfred, NY 14802, USA.
Journal of Materials Science Materials in Medicine (Impact Factor: 2.59). 11/2010; 22(1):19-28. DOI: 10.1007/s10856-010-4184-4
Source: PubMed


The ion release profiles and bioactivity of a series of Ti containing glass polyalkenoate cements. Characterization revealed each material to be amorphous with a T(g) in the region of 650-660°C. The network connectivity decreased (1.83-1.35) with the addition of TiO(2) which was also evident with analysis by X-ray photoelectron spectroscopy. Ion release from cements were determined using atomic absorption spectroscopy for zinc (Zn(2+)), calcium (Ca(2+)), strontium (Sr(2+)), Silica (Si(4+)) and titanium (Ti(4+)). Ions such as Zn(2+) (0.1-2.0 mg/l), Ca(2+) (2.0-8.3 mg/l,) Sr(2+) (0.1-3.9 mg/l), and Si(4+) (14-90 mg/l) were tested over 1-30 days. No Ti(4+) release was detected. Simulated body fluid revealed a CaP surface layer on each cement while cell culture testing of cement liquid extracts with TW-Z (5 mol% TiO(2)) produced the highest cell viability (161%) after 30 days. Direct contact testing of discs resulted in a decrease in cell viability of the each cement tested.

1 Follower
12 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: A glass series [ x SiO(2[ -y ])·0.36ZnO·0.17Na(2)O·0.05CaO (starting at x = 0.50, y = 0.08 TiO(2))] was formulated with TiO(2) substituting SiO(2). Each glass/silver-coated glass was characterized using X-ray diffraction, X-ray photoelectron spectroscopy (XPS), and scanning electron microscopy. Surface area analysis revealed significant changes after silver coating, 0.43-0.95 m(2)/g (control), to 0.53-1.85 m(2)/g (AU-1), and 0.20-1.11 m(2)/g (AU-2). Ion release from uncoated glasses included sodium (0.08 mg/L), calcium (0.07 mg/L), and zinc (0.008 mg/L), where silver-coated glasses presented 0.42 mg/L (silver), 0.33 mg/L (sodium), 0.02 mg/L (calcium), and 0.01 mg/L (zinc). Ag-coated glasses presented inhibition zones of 7.75 mm (control) compared to 1.04 mm (AU-2).
    Journal of Biomaterials Applications 07/2011; 27(4). DOI:10.1177/0885328211411000 · 2.20 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: A gallium (Ga) glass series (0.48SiO(2)-0.40ZnO-0.12CaO, with 0.08 mol% substitution for ZnO) was developed to formulate a Ga-containing Glass Polyalkenoate Cement (GPC) series. Network connectivity (NC) and X-ray Photoelectron Spectroscopy (XPS) was employed to investigate the role of Ga(3+) in the glass, where it is assumed to act as a network modifier. Ga-GPC series was formulated with E9 and E11 polyacrylic acid (PAA) at 50, 55 and 60 wt% additions. E11 working times (T(w)) ranged from 68 to 96 s (Lcon.) and 106 s for the Ga-GPCs (LGa-1 and LGa-2). Setting times (T(s)) ranged from 104 to 226 s (Lcon.) and 211 s for LGa-1 and LGa-2. Compression (σc) and biaxial flexural (σf) testing were conducted where Lcon. increased from 62 to 68 MPa, LGa-1 from 14 to 42 MPa and LGa-2 from 20 to 47 MPa in σc over 1-30 days. σf testing revealed that Lcon. increased from 29 to 42 MPa, LGa-1 from 7 to 32 MPa and LGa-2 from 12 to 36 MPa over 1-30 days.
    Journal of Materials Science Materials in Medicine 06/2012; 23(8):1823-33. DOI:10.1007/s10856-012-4624-4 · 2.59 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: This project investigates the characterization and solubility of a bioactive glass series where Strontium (Sr) and Sodium (Na) are substituted. X-ray diffraction (XRD) was employed to ensure that each starting material is amorphous. Differential Thermal Analysis (DTA) was used to determine the thermal profile of each material, in particular, the glass transition temperature (Tg), the crystallization temperature (Tc1) and the melting temperature (Tm). Magic Angle Spinning - Nuclear Magnetic Resonance (MAS-NMR) was used to probe the local 29Si environment. Simulated Body Fluid (SBF) testing revealed a CaP surface layer on each glass after 7 days.
    Bioengineering Conference (NEBEC), 2013 39th Annual Northeast; 01/2013
Show more